DarioHealth contracts with National Health Plan to provide behavioral health services to millions of members



The shares of DarioHealth Corp. traded up 17% after the company said it struck a deal with an anonymous national healthcare provider to make its behavioral health products available to millions of plan members.

Global digital health solutions company DarioHealth Corp. (DRIO: NASDAQ), which focuses on delivering digital therapies (DTx) designed to integrate life and behavioral sciences with software technology to deliver engaging therapeutic interventions, today announcement “It has entered into an agreement with one of the largest US national health plans (Plan) to offer its self-insured employer customers the Dario digital behavioral health solution as part of its behavioral health offering.”

The firm said the new contract will allow it to integrate its products and services with those of the health plan, providing access to millions of plan members.

DarioHealth has indicated that it expects the first of the new plan members to be uploaded to the platform during Q4 / 21. The company expects it to grow further and add additional users throughout the fiscal year / 22. The company said it will collect a monthly fee for members with access to the platform.

The company noted that improving access to mental health care remains a very high priority for individuals, employers, insurance companies and healthcare providers. The technology that enables and improves accessibility to care is a key element in increasing the networks of traditional providers.

The company mentioned that “Plan chose Dario’s digital behavioral health solution to help improve access by using the Dario behavioral health platform as a central digital engagement point to connect members to Dario tools,” to the coaching and comprehensive suite of Behavioral Health Plan resources ”.

Dario said in uses AI-based screening and triage capabilities to enhance the experience for plan members and create a unique set of care options tailored to their own specific needs.

Rick Anderson, President and CEO of North America at DarioHealth, commented, “Mental health care is complex and fraught with barriers to care. We are delighted to partner with The Plan to help address these issues and support their vision for a more accessible system and effective care that delivers better outcomes for their clients… This is a historic agreement for Dario who has the potential to generate millions of dollars in annual income. opportunities with this client. “

DarioHealth Corp. is a global digital therapy company headquartered in New York, NY. weight management. The company said it has created a next-generation AI-powered digital health solutions platform that “harnesses the power of evidence-based behavioral science to improve health” and helps individuals make change meaningful and lasting.

DarioHealth started the day with a market cap of approximately $ 222.5 million with approximately 16.5 million shares outstanding and an overdraft interest of approximately 5.4%. DRIO shares opened more than 11% higher today at $ 15.047 (+ $ 1.567, + 11.62%) from yesterday’s closing price of $ 13.48. The stock traded today between $ 14.67 and $ 16.54 per share and is currently trading at $ 15.85 (+ $ 2.37, + 17.58%).


1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or the members of his household have securities of the following companies mentioned in the article: None. He or the members of his household are remunerated by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are sponsors of the Streetwise Reports bulletin board: None. Click here for important information on referral fees.
3) Comments and opinions expressed are those of specific experts and not of Streetwise Reports or its managers. The information provided above is for informational purposes only and does not constitute a recommendation to buy or sell securities.
4) The article does not constitute investment advice. Each reader is encouraged to consult their financial professional and any action taken by a reader following the information presented here is at their own responsibility. By opening this page, each reader accepts and accepts the terms of use and the entire Streetwise Reports disclaimer. This article is not an investment solicitation. Streetwise Reports does not give general or specific investment advice, and information on Streetwise Reports should not be taken as a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the activities, products, services or titles of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or their family members, as well as those interviewed for articles and interviews on the Site, may have a long or short position on the titles mentioned. Directors, officers, employees or members of their immediate family are prohibited from making any purchases and / or sales of these securities on the open market or otherwise from the time of the decision to publish an article up to three days. working days after publication of the article. The foregoing ban does not apply to articles which, in essence, only repeat previously published company releases.
6) This article does not constitute medical advice. Streetwise Reports officers, employees and contributors are not licensed healthcare professionals. Readers should always contact their healthcare professionals for medical advice.



Leave A Reply